ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FUM Futura Medical Plc

35.80
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 35.80 35.80 36.10 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.61 108.56M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 35.80p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £108.56 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.61.

Futura Medical Share Discussion Threads

Showing 16901 to 16907 of 21425 messages
Chat Pages: Latest  677  676  675  674  673  672  671  670  669  668  667  666  Older
DateSubjectAuthorDiscuss
24/2/2023
14:09
Petroc has now highlighed that not all the relevant information is being published on a UK website and only biased information is being disclosed on the website as its known that Med3000 is not a ‘regular’ oral placebo! Its a medical device placebo gel that is being massaged in!

‘some forms of bias, such as publication bias, should be considered as fraud’



Bias and Fraud

There are numerous biases in medical research that render evidence from such research systematically misleading. Some of these biases are exacerbated by conflicts of interest, including fantastic financial incentives. The most important biases in medical research include confirmation bias, design bias, analysis bias, and publication bias. Arguably, some forms of bias, such as publication bias, should be considered as fraud. The pervasiveness of bias in medical research justifies one of the premises of the master argument for medical nihilism. Medical research is malleable due to the many biases, and such malleability allows for the production of evidence that suggests medical interventions are effective, whether or not they are in fact effective.

lbo
24/2/2023
13:40
So now according to the unqualified ramper hiding behind anonymity. The scientific principles of substantiation beyond a adequate and equivalent placebo which is accepted by the wider scientific and academic community, the FTC, the ASA and the courts to substantiate claims it works beyond what a similar placebo gel would are:

‘lies, fabrications, irrelevant comments and misinformation’

Thats a serious slanderous allegation against the FTC, the ASA and the Courts



Administrative Law Judge Upholds FTC's Complaint that POM Deceptively Advertised Its Products erectile dysfunction claims were false and unsubstantiated because the study on which the company relied did not show that POM Juice was any more effective than a placebo.



The absence of an adequate placebo (an inactive topical gel) for highlighted as a limitation by 3 commentators. One commentator said that without it, the clinical effectiveness could be attributed to the placebo effect of rubbing a gel

lbo
24/2/2023
11:44
‘The absence of an adequate placebo (an inactive topical gel) for highlighted as a limitation by 3 commentators. One commentator said that without it, the clinical effectiveness could be attributed to the placebo effect of rubbing a gel’






The precedent was set in a previous ruling by the ASA on another drug free medical device gel. Med3000 was also just the placebo in the FM57 study. Therefore Futura had initially believed Med3000 had no therapeutic effect. The FM57 study did not set out to measure the efficacy of Med3000. The ASA will therefore consider that its reported effectiveness by Futura was a ˜post-hoc finding’

The CAP Code required that objective claims, including medical claims for a CE-marked medical device, be backed by evidence

a certified Class IIb medical device. We understood that the device certification was granted by a body within the European Member States that had been designated to carry out conformity assessments under the Medical Device Directive

had been used as the placebo treatment in that study, and therefore the researcher had initially believed it had no therapeutic effect. The trial did not set out to measure the efficacy

its reported effectiveness by the advertiser was a post-hoc finding due to the risk of that being a false positive finding

We were also concerned that there was not an adequate placebo control in the trial. We, therefore, considered that the study did not provide adequate evidence for the claim ‘clinically proven’



One specialist commentator felt that the clinical effectiveness has not been demonstrated. The absence of an adequate placebo (an inactive topical gel) for highlighted as a limitation by 3 commentators. One commentator said that without it, the clinical effectiveness could be attributed to the placebo effect of rubbing a gel

lbo
24/2/2023
11:35
‘When promoting, selling or supplying products, companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly’


petroc - 23 Feb 2023 - 21:53:12 - 16545 of 16559

Why are there no placebo controlled studies?

Eroxon, was the ‘placebo’; used in FM57 and gave surprising results having efficacy approximately double that normally achieved in ED studies with regular placebos..

hxxps://hcp.eroxon.co.uk/

And now thanks to Petroc link we know that it is being admitted on a website that it is known that Med3000 was the placebo in FM57 and it is not a ˜regular placebo’ ie an oral placebo. Its a medical device placebo but it is just being compared to an oral placebo.

And no direct efficacy comparison study with a more similar medical device placebo gel is being carried out which again has not been adequately disclosed

lbo
24/2/2023
11:15
Stupid Petroc doesn't realise that every time he says 'there is loads of evidence to suggest it does work but cannot substantiate that with an adequately placebo controlled and blinded study. He is shooting himself in the foot. Because that means he doesn't have a shred of non deficient evidence to suggest to the ASA, FTC or courts that Eroxon does work! ROFLMAO

It doesn’t matter many reviewers on Farmaline have given testimonial it does work! The phase 3 trial was not designed to study the placebo Med3000 gel. It was designed to study a different product Med2005 so its results about Med3000 are a post hoc finding. And the medical device tests FM71 and consumer HUT were both deficient uncontrolled and unblinded. All were prone to many biases. What Petroc the ramper says it does work doesn't mean a single thing. In fact, given his record of making claims he cannot substantiate on bulletin boards. it's guaranteed to be a ‘form or fraud’

According to the FTC not disclosing clearly to consumers all these known limitations of the deficient med3000 medical device tests and not highlighting that med3000 is only being compared to regular oral placebos instead of a like for like placebo gel is a ‘form of fraud’




Selling brass as gold harms consumers independent of any effect

Since the placebo effect can be obtained from sugar pills, charging $200 for a device that is represented as a miracle cure but works no better than a dummy pill is a form of fraud. Thats not all. A placebo is necessary when scientists are searching for the marginal effect of a new drug or device, but once the study is over a reputable professional will recommend whatever works best. Medicine aims to do better than the placebo effect, which any medieval physician could achieve by draining off a little of the patients blood. If no one knows how to cure or ameliorate a given condition, then a placebo is the best thing going. Far better a placebo that causes no harm (the Q-Ray Ionized Bracelet is inert) than the sort of nostrums peddled from the back of a wagon 100 years ago and based on alcohol, opium, and wormwood. But if a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the con- sumer. See Kraft, Inc. v. FTC, 970 F.2d 311, 314 (7th Cir. 1992) (a statement violates the FTC Act If it is likely to mislead consumers, acting reasonably under the circumstances, in a material

lbo
23/2/2023
22:15
According to the FTC not disclosing clearly to consumers all these known limitations of the deficient med3000 medical device tests and not highlighting that med3000 is only being compared to regular oral placebos instead of a like for like placebo gel is a ‘form of fraud’



Selling brass as gold harms consumers independent of any effect

Since the placebo effect can be obtained from sugar pills, charging $200 for a device that is represented as a miracle cure but works no better than a dummy pill is a form of fraud. Thats not all. A placebo is necessary when scientists are searching for the marginal effect of a new drug or device, but once the study is over a reputable professional will recommend whatever works best. Medicine aims to do better than the placebo effect, which any medieval physician could achieve by draining off a little of the patients blood. If no one knows how to cure or ameliorate a given condition, then a placebo is the best thing going. Far better a placebo that causes no harm (the Q-Ray Ionized Bracelet is inert) than the sort of nostrums peddled from the back of a wagon 100 years ago and based on alcohol, opium, and wormwood. But if a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the con- sumer. See Kraft, Inc. v. FTC, 970 F.2d 311, 314 (7th Cir. 1992) (a statement violates the FTC Act If it is likely to mislead consumers, acting reasonably under the circumstances, in a material

lbo
23/2/2023
22:02
Petroc has now for highlighed that not all the relevant information is being published on a UK website and only biased information is being disclosed on the website as its known that Med3000 is not a regular oral placebo! Its a medical device placebo gel that is being massaged in!



‘some forms of bias, such as publication bias, should be considered as fraud’



Bias and Fraud

There are numerous biases in medical research that render evidence from such research systematically misleading. Some of these biases are exacerbated by conflicts of interest, including fantastic financial incentives. The most important biases in medical research include confirmation bias, design bias, analysis bias, and publication bias. Arguably, some forms of bias, such as publication bias, should be considered as fraud. The pervasiveness of bias in medical research justifies one of the premises of the master argument for medical nihilism. Medical research is malleable due to the many biases, and such malleability allows for the production of evidence that suggests medical interventions are effective, whether or not they are in fact effective.

lbo
Chat Pages: Latest  677  676  675  674  673  672  671  670  669  668  667  666  Older

Your Recent History

Delayed Upgrade Clock